Table 1 Clinical and CMR characteristics of patients with and without "physiologic basal septal LGE".
"Physiologic basal basal LGE" | p-value | ||
|---|---|---|---|
Clinical variables | Present (n = 73) | Absent (n = 357) | |
Age (years) | 59.2 ± 12.7 | 55.1 ± 14.9 | 0.030 |
Male (n, %) | 51 (69.9) | 230 (64.4) | 0.374 |
BMI (g/m2) | 29.0 ± 5.1 | 28.2 ± 5.5 | 0.215 |
GFR (mL/min) | 82.3 ± 22.1 | 77.4 ± 22.1 | 0.098 |
Smoking (n, %) | 19 (26.0) | 105 (29.4) | 0.561 |
Hyperlipedemia (n, %) | 29 (39.7) | 140 (39.2) | 0.935 |
Diabetes (n, %) | 10 (13.7) | 61 (17.1) | 0.477 |
Hypertension (n, %) | 32 (43.8) | 139 (38.9) | 0.436 |
History of coronary disease (n, %) | 20 (27.4) | 129 (36.1) | 0.153 |
NYHA class | |||
Class I - II (n, %) | 23 (63.9) | 140 (61.9) | |
Class III - IV (n, %) | 13 (36.1) | 86 (38.1) | 0.823 |
CMR variables | |||
- LV anteroseptal wall thickness (mm) | 10.8 ± 3.5 | 10.8 ± 4.1 | 0.963 |
- LV end diastolic volume index (mL/m2) | 86.2 ± 40.4 | 97.0 ± 43.2 | 0.051 |
- LV mass index (mL/m2) | 81.3 ± 27.6 | 86.2 ± 28.8 | 0.185 |
- LV ejection fraction (%) | 53.8 ± 19.4 | 48.1 ± 22.2 | 0.045 |
- RV end diastolic volume index (mL/m2) | 63.2 ± 18.2 | 65.8 ± 24.5 | 0.374 |
- RV ejection fraction (%) | 57.7 ± 13.0 | 54.0 ± 15.5 | 0.061 |
- Presence of LGE (n, %) | 41 (56.2) | 243 (68.1) | 0.050 |
- Total fibrosis (≥ 5 SD threshold) (mL) | 10.6 ± 14.9 | 12.4 ± 17.9 | 0.440 |
- Percentage of fibrosis (≥ 5 SD threshold) (%) | 9.8 ± 12.9 | 11.1 ± 14.5 | 0.44 |